Banerjee A - Search Results

1

Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort.

Handy A, Banerjee A, Wood AM, Dale C, Sudlow CLM, Tomlinson C, Bean D, Thygesen JH, Mizani MA, Katsoulis M, Takhar R, Hollings S, Denaxas S, Walker V, Dobson R, Sofat R; CVD-COVID-UK Consortium. Handy A, et al. Among authors: banerjee a. Heart. 2022 May 25;108(12):923-931. doi: 10.1136/heartjnl-2021-320325. Heart. 2022. PMID: 35273122 Free PMC article.

2

Looking through the PRISM: new insights for young patients with atrial fibrillation and stroke.

Banerjee A, Lip GY. Banerjee A, et al. Cerebrovasc Dis. 2011;32(4):383-4. doi: 10.1159/000331464. Epub 2011 Sep 15. Cerebrovasc Dis. 2011. PMID: 21921602 Free article. No abstract available.

3

Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study.

Banerjee A, Lane DA, Torp-Pedersen C, Lip GY. Banerjee A, et al. Thromb Haemost. 2012 Mar;107(3):584-9. doi: 10.1160/TH11-11-0784. Epub 2011 Dec 21. Thromb Haemost. 2012. PMID: 22186961

4

Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project.

Banerjee A, Taillandier S, Olesen JB, Lane DA, Lallemand B, Lip GY, Fauchier L. Banerjee A, et al. Eur J Heart Fail. 2012 Mar;14(3):295-301. doi: 10.1093/eurjhf/hfs005. Epub 2012 Jan 30. Eur J Heart Fail. 2012. PMID: 22294759 Free article.

5

Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project.

Banerjee A, Taillandier S, Olesen JB, Lane DA, Lallemand B, Lip GY, Fauchier L. Banerjee A, et al. Int J Cardiol. 2013 Sep 10;167(6):2682-7. doi: 10.1016/j.ijcard.2012.06.118. Epub 2012 Jul 15. Int J Cardiol. 2013. PMID: 22795403

6

Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.

Banerjee A, Fauchier L, Vourc'h P, Andres CR, Taillandier S, Halimi JM, Lip GY. Banerjee A, et al. J Am Coll Cardiol. 2013 May 21;61(20):2079-87. doi: 10.1016/j.jacc.2013.02.035. Epub 2013 Mar 21. J Am Coll Cardiol. 2013. PMID: 23524209 Free article.

7

Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project.

Banerjee A, Clementy N, Haguenoer K, Fauchier L, Lip GY. Banerjee A, et al. Am J Med. 2014 Oct;127(10):972-8. doi: 10.1016/j.amjmed.2014.05.035. Epub 2014 Jun 12. Am J Med. 2014. PMID: 24929021 Free article.

8

Changes in renal function after catheter ablation of atrial fibrillation are associated with CHADS2 and CHA2DS2-VASc scores and arrhythmia recurrences.

Kornej J, Hindricks G, Banerjee A, Arya A, Sommer P, Rolf S, Husser D, Lip GY, Bollmann A. Kornej J, et al. Among authors: banerjee a. Heart. 2015 Jan;101(2):126-31. doi: 10.1136/heartjnl-2014-306013. Epub 2014 Oct 3. Heart. 2015. PMID: 25281600

9

The Health Impact Fund: how might it work for novel anticoagulants in atrial fibrillation?

Banerjee A, Pogge T. Banerjee A, et al. Glob Heart. 2014 Jun;9(2):255-261.e2. doi: 10.1016/j.gheart.2014.01.005. Glob Heart. 2014. PMID: 25667097 Free article. Review.

10

Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study.

Blann AD, Banerjee A, Lane DA, Torp-Pedersen C, Lip GY. Blann AD, et al. Among authors: banerjee a. Int J Cardiol. 2015 Dec 15;201:693-8. doi: 10.1016/j.ijcard.2015.08.074. Epub 2015 Aug 10. Int J Cardiol. 2015. PMID: 26379097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,032 results

Search Page

Filters